Clinical Pharmacology and the Best Use of Public Research Investment

Improving the Efficiency of Clinical Pharmacology Studies

“…Efficiency in the planning, execution, monitoring, and reporting of CP studies has not kept pace with innovation in other sectors of drug development, for example, model‐informed drug development (MIDD) and electronic regulatory submissions. Thus, CP studies are ripe for disruptive innovation to accelerate drug development, allowing for earlier identification of drugs with low potential for success—the “kill fast” concept that saves money 2 . In this commentary, 10 suggestions are made to improve the efficiency of CP studies.…”

“…Thus, CP studies are ripe for disruptive innovation to accelerate drug development, allowing for earlier identification of drugs with low potential for success-the "kill fast" concept that saves money. 2 In this commentary, 10 suggestions are made to improve the efficiency of CP studies.…”